Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05367609 · ClinicalTrials.gov registry record · NA

Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)

A NA study of Spine Fusion and PPAP, sponsored by Senthil Sadhasivam.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
3
Study locations

NCT05367609 is a NA study of Spine Fusion and PPAP that is actively recruiting participants, run by Senthil Sadhasivam. The registered enrollment target is 300 participants, above the 87-participant average among 6 other Spine Fusion trials with a reported enrollment target (245% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05367609, a NA study of Spine Fusion and PPAP, is actively recruiting participants, sponsored by Senthil Sadhasivam.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this collaborative CTSA application is to develop an innovative perioperative precision analgesia platform (PPAP) to improve analgesia and reduce serious immediate and long-term adverse outcomes of perioperative opioids in children undergoing painful surgery.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Preoperative Genotyping

Study Locations (3)

California

  • University of California - San Francisco

Indiana

  • Riley Children's Hospital - Indianapolis

Pennsylvania

  • UPMC Children's Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2022-09-20
Est. Completion 2026-09
Phase NA

Sponsor

Senthil Sadhasivam

7 total trials

What the Registry Record Tells You About NCT05367609

The ClinicalTrials.gov registry entry for NCT05367609 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 87-participant average among 6 other Spine Fusion trials with a reported enrollment target (245% higher). The listed sponsor is Senthil Sadhasivam, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Spine Fusion appearing as the primary indexed condition, and to 1 intervention - of which Preoperative Genotyping is the first listed.

NCT05367609 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Indiana, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05367609 about?

NCT05367609 is a clinical study titled "Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)". The purpose of this collaborative CTSA application is to develop an innovative perioperative precision analgesia platform (PPAP) to improve analgesia and reduce serious immediate and long-term adverse outcomes of perioperative opioids in children undergoing painful surgery.

What is the current status of trial NCT05367609?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2022-09-20. Estimated completion is 2026-09.

What conditions does trial NCT05367609 study?

This clinical trial studies the following conditions: Spine Fusion, PPAP.

What interventions are being tested in trial NCT05367609?

The interventions under investigation include: Preoperative Genotyping (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05367609?

This trial is sponsored by Senthil Sadhasivam, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05367609 being conducted?

This trial has 3 study locations across California, Indiana, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spine Fusion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.